cobaltiprotoporphyrin has been researched along with Goldblatt Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, NG; Botros, FT; Drummond, G; Goodman, AI; Olszanecki, R; Omura, S; Rezzani, R; Rodella, L; Stec, DE | 1 |
1 other study(ies) available for cobaltiprotoporphyrin and Goldblatt Syndrome
Article | Year |
---|---|
Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway.
Topics: Animals; Apoptosis; Blood Pressure; Blotting, Western; Cell Nucleus; Creatine; Cyclooxygenase 2; DNA Fragmentation; Gene Expression Regulation, Enzymologic; Genetic Vectors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hypertension, Renovascular; Kidney Diseases; Protoporphyrins; Rats; Rats, Sprague-Dawley; Renal Artery; Retroviridae; RNA, Antisense; Signal Transduction; Tyrosine | 2007 |